Pfizer | PFE - Passività Correnti





Passività Correnti Cambiamento Data
AbbVie USD 41.64B 458M 2026-06
Abbott USD 18.38B 1.88B 2026-03
ALKERMES USD 662.09M 62.59M 2026-06
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 32.27B 1.19B 2026-06
Biogen USD 3.9B 18.7M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Coherus Biosciences USD 75.51M 56.82M 2026-06
Drreddys Laboratories INR 154.49B 13.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Glaxosmithkline GBP 20.72B 1.71B 2026-09
J&J USD 55.46B 562M 2026-09
Medtronic USD 11.8B 141M 2026-06
Merck USD 27.73B 786M 2026-06
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Sanofi EUR 31.93B 1.92B 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Zoetis USD 2.06B 8M 2026-06